To identify those GFAP-isoform induced transcriptomic changes that are relevant for astrocytoma malignancy, we compared our in vitro transcriptomic data to the TCGA derived patient transcriptomic data (Supplementary Figure 3A-3B). The gene discussed is GFAP; the disease is astrocytoma (excluding glioblastoma).